Why Did Indaptus Therapeutics Surge 64% In After-Hours Trading?
at www.benzinga.com (Tue, 23-Dec 10:12 PM)
KALA BIO Secures $6 Million Investment and Appoints David E. Lazar as CEO—Strategic Shift in Focus on the Horizon
Market Chameleon (Mon, 1-Dec 9:53 AM)
